Skip to content
Editorial Open access

Hypertrophic Cardiomyopathy in the Era of Precision Medicine: Redefining Diagnosis, Therapeutics and Risk

Aug 2026 · Cardiac failure review · Vol 12 · 0 citations · 13 references
Medicine

TL;DR

Findings reinforce the concept of HCM as a spectrum of diseases rather than a single genetic entity, setting the stage for more individualised approaches to diagnosis, counselling and management.

Abstract

clinical monitoring. Patients with sarcomeric variants generally have worse prognosis than those without, including earlier disease onset and higher rates of sudden cardiac death, heart failure and arrhythmias. 3 Historically, HCM was regarded as a monogenic disorder caused by pathogenic variants in sarcomeric genes. While MYH7 and MYBPC3 continue to account for the majority of genetically confirmed cases, contemporary research has revealed a more complex and heterogeneous genetic architecture. Recent gene re-evaluations and variant reclassifications have highlighted the role of non-sarcomeric genes, including FHOD3 , ALPK3 , CSRP3 and TRIM63 , as contributors to HCM phenotypes. 3 Common genetic variants play a substantial role in HCM susceptibility and disease expression, with genome-wide association studies identifying 70 susceptibility loci associated with HCM risk. Polygenic risk scores derived from these common variants significantly modify disease penetrance, severity and outcomes, particularly in pathogenic variant carriers where penetrance differs. 3 These findings have important implications for clinical practice; they reinforce the concept of HCM as a spectrum of diseases rather than a single genetic entity, setting the stage for more individualised approaches to diagnosis, counselling and management.

Read PDF

Similar papers

Open access Aug 2026

Phenotype and outcome of patients with hypertrophic cardiomyopathy MYH7 variants: A longitudinal cohort study.

Most patients with MYH7-related HCM presented with a benign phenotype over the long term, and the risks of AF, SCD, and worsening HF throughout life justify regular monitoring, and the need to look for particular genetic profiles that may potentially help tailored management strategies.

Catarina Gregório, M. Vilela, Ana Beatriz Garcia et al. · 0 citations
Open access Aug 2026

Impact of variant reclassification on genetic testing yield and clinical outlook in patients with hypertrophic cardiomyopathy.

Systematic reclassification of genetic variants led to a refinement of variant classification accuracy due to downgrading of 5.5% of P/LP variants, although 18.3%VUS/B/LB were upgraded to P/LP.

A. Del Franco, Valeria Setti, Federica Colio et al. · 0 citations
Review Open access Sep 2026

The Multifaceted Role of the FLNC Gene in Hereditary Cardiomyopathies and Prognosis

This narrative review summarizes FLNC molecular biology, genotype-phenotype relationships, imaging features, arrhythmic risk, and implications for clinical management and discusses the limited evidence linking FLNCtv to arrhythmogenic mitral valve prolapse with mitral annular disjunction.

M. d'Apolito, A. Ranaldi, Teresa Gaudiano et al. · 0 citations
Aug 2026

Imaging signatures of high-risk arrhythmogenic genotypes in dilated cardiomyopathy.

Compared with TTNtv and genotype-negative DCM, HRAv is characterized by a distinct CMR tissue phenotype marked by more extensive myocardial injury and fibrosis, despite similar ventricular remodeling and systolic impairment, suggesting that CMR tissue characterization may help identify genotype-associated phenotypic di...

Zhi-Gang Zhang, Yang-Jie Li, Yuan-Wei Xu et al. · 0 citations
Open access Sep 2026

A multiancestry polygenic risk score improves stratification in patients with hypertrophic cardiomyopathy

A multiancestry polygenic risk score for hypertrophic cardiomyopathy is developed and its association with the disease in a heterogeneous national population is demonstrated and support the integration of multiancestry PRSs into HCM risk assessment and prognostication.

Harshvir S. Bal, A. Pampana, Amrita Nayak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.